- Visibility 209 Views
- Downloads 40 Downloads
- Permissions
- DOI 10.18231/j.ijashnb.2021.008
-
CrossMark
- Citation
Vision improvement after trans-sphenoidal resection of pituitary macroadenoma
- Author Details:
-
Sumit Prinja *
-
Varun Aggarwal
-
Ramandeep Singh
-
Bhumika Trivedi
-
Dipesh
Abstract
Introduction: Pituitary adenomas are tumours that occur in the Pituitary gland. Depending on the size it can be divided into Microadenoma (<10mm) and Macroadenoma(>10mm). It can present with endocrine manifestations secondary to hypo or hyper function of pituitary gland and ophthalmological manifestations due to mass effect.
Case Report: A 36-year-old female was admitted to our institution with complaints of loss of vision of right eye, headache and amenorrhea for 3 months, which were progressive in nature. Her MRI Scan revealed a well-defined sellar mass, measuring 27 x 23.18 mm, with suprasellar extension, causing expansion of pituitary fossa and superiorly extending into Hypothalamus with mild compression over optic chiasma. Prolactin level was 72.16 ng/ml. Surgery was done under general anesthesias, by Endoscopic assisted trans-sphenoidal approach. The adenoma was completely removed. Sella opening was closed by synthetic graft. On awakening from anesthesias visual acuity in right eye was immediately and completely restored.
Conclusion: Pituitary adenoma is a complex set of benign tumours that present with hypersecretory syndrome and mass effect. An appropriate imaging of pituitary region using MRI and endocrinological consultation is the standard for detection of pituitary adenoma. Although, medical management and radiotherapy offer effective treatment for these tumours in specific situations, Endoscopic Trans-sphenoidal approach continues to provide optimal outcomes with low incidence of morbidity.
Introduction
Pituitary adenomas are tumors that occur in Pituitary gland. Pituitary adenomasare generally divided into three categories depending upon their biological function – Benign adenoma, Invasive adenoma, and Carcinomas. Mostly adenomas are benign, approximately 35% are invasive and just 0.1 to 0.2 % are carcinomas.[1] Pituitary adenomas comprise 10-15% of intracranial neoplasm andtheirestimated prevalence rate is 17%.[2], [3] Approximately 1 in 1000 people develops Pituitary adenoma. Pituitary adenomas are common in sellar area. Micro-adenomas are tumors measuring less than 10 mm in diameter and those of more than 10 mm are termed macro-adenomas. Pituitary adenomas are present with endocrine manifestations secondary to hypo or hyper function of pituitary gland and ophthalmological manifestations due to mass effect. When the tumor grows beyond the confines of sella turcica, it commonly affects visual pathway and visual field deficit are present. Symptoms depend on the presence of Pituitary hypersecretion, absence or reducedhormonal level, destruction of normal Pituitary gland. [4], [5]
Pituitary adenomasare usually diagnosed by radiographic examination, history & blood testing for hormonal level.
Here, we present the case of patient with Pituitary macro-adenoma with loss of vision, headache and amenorrhea.
Case Report
A 36-year-old femalewas admitted to our institution with complaints of loss of vision of right eye, headache and amenorrhea for 3 months. Symptoms were progressive in nature.General and systemic examination was found to be normal. Her MRI Scan revealed a well-defined sellar mass, measuring 27 x 23.18 mm, with suprasellar extension, causing expansion of pituitary fossa andsuperiorly extending into Hypothalamus with mild compression over optic chiasma. Her prolactin level was 72.16 ng/ml. Initial diagnosis was pituitary adenoma. Surgery was done under general anesthesia, by Endoscopic assisted Transsphenoidal approach. The adenoma was completely removed. Sella opening was closed by synthetic graft. On awakening from anesthesia visual acuity in right eye was immediately and completely restored. There was some CSF leakage during the surgery that was dealt with at the time. On first post-operative dayvisual acuity was checked and was found 5/6.Intravenous antibiotics and anti-inflammatory drugs were given for 7 days then patient was discharged.


Discussion
The Pituitary gland is about 2 to 8 mm in size and weight about 0.5 g. It is located within the sella turcica of sphenoid bone at the base of skull & covered by dural fold. Various important structures are present around Pituitary gland. The cavernous sinus and internal carotid artery are present on either side of it. The optic chiasma lies about 10 mm above it. The pituitary gland has two lobes. Anterior lobe secretes seven hormones like TSH, ACTH, GH, FSH, LH & Prolactin. Posterior lobe secretes two hormones- Vasopressin and Oxytocin. Pierre Marie was the first to describe a disease that involved the pituitary gland.[6], [7]
Pituitary tumors comprise 10-15% of intracranial neoplasm. Pituitary tumors can be classified on the basis of size. Macro-adenomas are more than 10 mm in diameter and micro-adenomas are less than 10mm in diameter. The tumor can also be classified as Chromo phobic, Acidophilic and Basophilic, depending upon the basis of histological staining. The tumors can also be divided on the basis of immune-histochemical staining & by serum hormone level, into secreting and non-secreting. The secreting tumorsconstitute 75% of pituitary adenoma.[8], [9] They include:
PRL cell adenoma
Growth hormone
Mix GH & PRL adenoma
Thyrotropin releasing hormone cell adenoma
ACTH cell adenoma
LSH & FSH cell adenoma
Prolactinomas comprise 40-50% of all pituitary adenoma. Prolactinomas generally occur in reproductive aged females and manifest with amenorrhea, galactorrhea. In males, it presents with gynecomastia, testicular atrophy, reduced body hair and impotence.[10] Pituitary adenomas can also present with sudden onset of headache and loss of vision due to hemorrhage and necrosis of tumor as pituitary apoplexy.[11]
Diagnosis of pituitary adenomas is based upon radiological imaging (CT and MRI) and measurement ofserum hormone level. They can be hyperdense oriso-dense compared with adjacent brain tissue and can show homogenous contrast enhancement with contrast material.[12]
Differential diagnosis includes olfactory neuroblastoma, Germinoma, Rhabdomyosarcoma.[13]
Pituitary adenomas can be treated by medical therapy, surgery and radiation therapy depending upon size, sign and symptom.
Conclusion
Pituitary adenoma is a complex set of benign tumors that present with hypersecretory syndrome and mass effect. An appropriate imaging of pituitary region using MRI and endocrinologic consultation is the standard for detection of pituitary adenoma. Although, medical management and radiotherapy offer effective treatment for these tumors in specific situations, Endoscopic Trans-sphenoidal approach continues to provide optimal outcomes with low incidence of morbidity.
Conflicts of Interest
All contributing authors declare no conflicts of interest.
Source of Funding
None.
References
- Basari R, Srivastava V, Vasenwala S, Ansari H. Pituitary adenoma: A case report with special emphasis on approach to diagnosis. Clin Cancer Investig J. 2014;3:264-7. [Google Scholar] [Crossref]
- Ezzat S, Asa SL, Couldwell W, Barr C, Dodge W, Vance M. The prevalence of pituitary adenomas. Cancer. 2004;101(3):613-9. [Google Scholar] [Crossref]
- Costello RT. Subclinical adenoma of pituitary gland. Am J Pathol. 1936;12:205-16. [Google Scholar]
- Raju KV, Ruby MV. Pituitary macroadenoma: A case presentation. Kerala J Ophthalmol. 2006;18:58-60. [Google Scholar]
- Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management.. Endocrine Relat Cancer. 2001;8:287-305. [Google Scholar] [Crossref]
- Kovacs K, Horvath E. Pathology of Pituitary Tumors. Endocrinol Metabol Clin North Am. 1987;16(3):529-51. [Google Scholar] [Crossref]
- Riskind PN, Richardson EP. Clinicopathologic conference-SN. N Engl J Med. 1986;314. [Google Scholar]
- Lopes M. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 2017;134(4):521-95. [Google Scholar] [Crossref]
- Seltzer J. Outcomes following transsphenoidal surgical management of incidental pituitary adenomas: a series of 52 patients over a 17-year period. J Neurosurg. 2019;130:158-1592. [Google Scholar]
- Molitch M. Diagnosis and Treatment of Pituitary Adenomas. JAMA. 2017;317(5). [Google Scholar] [Crossref]
- Nawar R, AbdelMannan D, Selman W, Arafah B. Analytic Review: Pituitary Tumor Apoplexy: A Review. J Intensive Care Med. 2008;23(2):75-90. [Google Scholar] [Crossref]
- Jane J, Michael M, Laws E. Surgical Treatment of Pituitary Adenomas. . 2019. [Google Scholar]
- Levy M, Matharu M, Goadsby P. Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol. 2003;10(2):169-73. [Google Scholar] [Crossref]
How to Cite This Article
Vancouver
Prinja S, Aggarwal V, Singh R, Trivedi B, Dipesh . Vision improvement after trans-sphenoidal resection of pituitary macroadenoma [Internet]. IP Indian J Anat Surg Head Neck Brain. 2021 [cited 2025 Nov 03];7(1):39-41. Available from: https://doi.org/10.18231/j.ijashnb.2021.008
APA
Prinja, S., Aggarwal, V., Singh, R., Trivedi, B., Dipesh, (2021). Vision improvement after trans-sphenoidal resection of pituitary macroadenoma. IP Indian J Anat Surg Head Neck Brain, 7(1), 39-41. https://doi.org/10.18231/j.ijashnb.2021.008
MLA
Prinja, Sumit, Aggarwal, Varun, Singh, Ramandeep, Trivedi, Bhumika, Dipesh, . "Vision improvement after trans-sphenoidal resection of pituitary macroadenoma." IP Indian J Anat Surg Head Neck Brain, vol. 7, no. 1, 2021, pp. 39-41. https://doi.org/10.18231/j.ijashnb.2021.008
Chicago
Prinja, S., Aggarwal, V., Singh, R., Trivedi, B., Dipesh, . "Vision improvement after trans-sphenoidal resection of pituitary macroadenoma." IP Indian J Anat Surg Head Neck Brain 7, no. 1 (2021): 39-41. https://doi.org/10.18231/j.ijashnb.2021.008